Provided by Tiger Trade Technology Pte. Ltd.

Ventyx Biosciences, Inc.

14.00
0.0000
Volume:- -
Turnover:76.26M
Market Cap:1.00B
PE:-9.34
High:14.00
Open:14.00
Low:14.00
Close:14.00
52wk High:25.00
52wk Low:0.7830
Shares:71.75M
Float Shares:53.56M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4991
EPS(LYR):-1.9732
ROE:-45.35%
ROA:-28.47%
PB:5.25
PE(LYR):-7.10

Loading ...

Ventyx Biosciences Shareholders Approve Merger With Eli Lilly

TIPRANKS
·
Mar 04

NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM

Reuters
·
Mar 04

Ventyx Biosciences Inc. Held Special Stockholder Meeting

Reuters
·
Mar 04

Ventyx Faces Eli Lilly Acquisition, Delisting and Litigation

TIPRANKS
·
Feb 24

Ventyx Faces New York Shareholder Lawsuits Over Merger Proxy Disclosures

Reuters
·
Feb 24

Ventyx Biosciences subsidiary gets orphan designation for pericarditis treatment

TIPRANKS
·
Feb 14

Ventyx Biosciences call volume above normal and directionally bullish

TIPRANKS
·
Jan 24

Ventyx Biosciences Inc. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
Jan 23

Ventyx Biosciences Sets Special Cash Bonuses Amid Lilly Merger

TIPRANKS
·
Jan 23

LifeSci Capital Sticks to Its Hold Rating for Ventyx Biosciences (VTYX)

TIPRANKS
·
Jan 11

Eli Lilly (LLY) Buys Ventyx Biosciences in $1.2 Billion Deal

TIPRANKS
·
Jan 09

Ventyx Biosciences Cut to Equal-Weight From Overweight by Wells Fargo

Dow Jones
·
Jan 08

Deals of the day-Mergers and acquisitions

Reuters
·
Jan 08

Ventyx Biosciences Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $14 From $21

THOMSON REUTERS
·
Jan 08

Ventyx Biosciences : Oppenheimer Cuts to Perform From Outperform

THOMSON REUTERS
·
Jan 08

Ventyx Biosciences Cut to Hold From Buy by Canaccord Genuity

Dow Jones
·
Jan 08

Hold Rating Maintained on Eli Lilly’s Acquisition of Ventyx Biosciences Amid Limited Upside and NLRP3 Uncertainty

TIPRANKS
·
Jan 08

Ventyx Biosciences Inc : H.c. Wainwright Cuts to Neutral Rating

THOMSON REUTERS
·
Jan 08

Ventyx Biosciences downgraded to Neutral from Buy at UBS

TIPRANKS
·
Jan 08

Eli Lilly (LLY.US) Confirms Acquisition of Ventyx Biosciences (VTYX.US) at $14 Per Share

Stock News
·
Jan 08